Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
-0,21%
1 091,51
-2,30
-0,21%
—1 093,811 096,521 100,221 091,51——
SIXC
Communications
SIXC
Communications
SIXC
+0,22%
610,11
+1,34
+0,22%
—608,77608,77612,97608,77——
SIXE
Energy
SIXE
Energy
SIXE
-1,34%
1 237,98
-16,83
-1,34%
—1 254,811 253,011 253,871 226,33——
SIXI
Industrials
SIXI
Industrials
SIXI
-0,93%
1 744,71
-16,40
-0,93%
—1 761,111 764,271 766,881 744,71——
SIXM
Financials
SIXM
Financials
SIXM
-0,37%
640,18
-2,40
-0,37%
—642,58644,87648,48640,18——
SIXR
Staples
SIXR
Staples
SIXR
-0,18%
849,58
-1,55
-0,18%
—851,13855,66858,75845,56——
SIXRE
Real estate
SIXRE
Real estate
SIXRE
-0,23%
217,48
-0,50
-0,23%
—217,98217,98218,65216,88——
SIXT
Technology
SIXT
Technology
SIXT
+1,52%
3 260,69
+48,86
+1,52%
—3 211,833 227,213 268,383 226,55——
SIXU
Utilities
SIXU
Utilities
SIXU
-0,69%
942,45
-6,53
-0,69%
—948,98948,58957,83941,97——
SIXV
Health care
SIXV
Health care
SIXV
-0,52%
1 466,80
-7,72
-0,52%
—1 474,521 479,031 481,041 466,80——
SIXY
Discretionary
SIXY
Discretionary
SIXY
+0,22%
2 397,50
+5,38
+0,22%
—2 392,122 396,952 421,222 382,32——
J4D:FRA
Kenvue Inc
€14,50
-1,96%
(-0,29) 1D
30 Apr., 22:00:00 GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for J4D...
Open
€14,34
High
€14,50
Low
€14,34
Mkt. cap
33,46 mjd
Avg. vol.
96,00
Volume
0,00
52-wk high
€22,20
52-wk low
€11,83
No. of employees
22 k
News stories
From sources across the web
Profile
Kenvue Inc. is an American consumer health company. Formerly the Consumer Healthcare division of Johnson & Johnson, Kenvue owns well-known brands such as Aveeno, Band-Aid, Benadryl, Combantrin, Zyrtec, Johnson's, Listerine, Lactaid, Mylanta, Neutrogena, Trosyd, Calpol, Tylenol, and Visine. Kenvue is incorporated in Delaware and was originally headquartered in the Skillman section of Montgomery Township, New Jersey, before relocating to Summit, New Jersey. Johnson & Johnson announced in November 2021 that it would spin off its consumer health division as a separate company. The new company was named Kenvue in September 2022, and its initial public offering took place in May 2023, raising $3.8 billion in the largest U.S. IPO since 2021, with an initial valuation of about $41 billion. Johnson & Johnson initially retained more than 90% ownership before completing a full separation through a share exchange in July 2023. Kenvue was subsequently added to the S&P 500 Dividend Aristocrats index. CEO Thibaut Mongon initially led Kenvue, which employed about 22,200 people in 2022. Following Mongon’s termination in 2025, Kirk Perry was named interim CEO. Wikipedia
About Kenvue Inc
CEO-
Employees21,9 k
Founded23 Feb. 2022
HeadquartersSummit, New Jersey, Verenigde State van Amerika
SectorPersonal care products
Websitekenvue.com
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Mrt. 2025
Jun. 2025
Sep. 2025
Des. 2025
Revenue
3,74 mjd
3,84 mjd
3,76 mjd
3,78 mjd
Cost of goods sold
1,57 mjd
1,57 mjd
1,53 mjd
1,63 mjd
Cost of revenue
1,57 mjd
1,57 mjd
1,53 mjd
1,63 mjd
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1,54 mjd
1,50 mjd
1,51 mjd
1,51 mjd
Operating expense
1,55 mjd
1,51 mjd
1,51 mjd
1,48 mjd
Total operating expenses
3,12 mjd
3,08 mjd
3,04 mjd
3,11 mjd
Operating income
625,00 m
760,00 m
726,00 m
674,00 m
Other non operating income
-
1,00 m
10,00 m
7,00 m
EBT including unusual items
458,00 m
588,00 m
526,00 m
427,00 m
EBT excluding unusual items
525,00 m
656,00 m
623,00 m
574,00 m
Income tax expense
136,00 m
168,00 m
128,00 m
97,00 m
Effective tax rate
29,69%
28,57%
24,33%
22,72%
Other operating expenses
13,00 m
5,00 m
1,00 m
-30,00 m
Net income
322,00 m
420,00 m
398,00 m
330,00 m
Net profit margin
8,61%
10,94%
10,57%
8,73%
Earnings per share
0,24
0,29
0,28
0,27
Interest and investment income
13,00 m
13,00 m
14,00 m
11,00 m
Interest expense
-107,00 m
-107,00 m
-107,00 m
-109,00 m
Net interest expenses
-94,00 m
-94,00 m
-93,00 m
-98,00 m
Depreciation and amortization charges
-
-
-
-
EBITDA
761,00 m
902,00 m
867,00 m
713,00 m
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer